Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
KETOTIFEN FUMARATE
Laboratoires Thea
0.25/1 Mg/Ml
Eye Drops Solution
2011-11-04
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zaditen 0.25 mg/ml_, _eye drops, solution in single-dose containers. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 0.4 ml contains 0.138 mg ketotifen fumarate corresponding to 0.1 mg ketotifen. Each drop contains 9.5 microgram ketotifen fumarate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution in single-dose containers. Clear, colourless to faintly yellow solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic treatment of seasonal allergic conjunctivitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults, elderly and children (age 3 and older): one drop of Zaditen into the conjunctival sac twice a day. The contents of a single-dose container are sufficient for one administration into both eyes. The contents remain sterile until the original closure is broken. To avoid contamination do not touch any surface with the tip of the container. Safety and effectiveness in paediatric patients below the age of 3 years have not been established. 4.3 CONTRAINDICATIONS Hypersensitivity to ketotifen or to any of the excipients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE No special warning. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION If Zaditen is used concomitantly with other eye medications there must be an interval of at least 5 minutes between the medications. The use of oral dosage forms of ketotifen may potentiate the effects of CNS depressants, antihistamines and alcohol. Although this has not been observed with Zaditen eye drops, the possibility of such effects cannot be excluded. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 04/11/2011_ _C Read the complete document